The Board of directors needs to do a couple of th
Post# of 148159
The company is going to have a cash crunch if they already dont have one now. The board needs to pressure NP to make decisions on the Covid trials. First, see if you can find a big Pharma partner . It has worked for many other young biotechs so activate conversations with those 11 we were talking to last year. Second , once Canada, the UK and other countries have what they need put them on an internal 30 day timeframe for an EUA . If we don’t have any results from them in 30 days and we don’t have an influx of BP dollars, shut down the 140 person trial completely and finish the Long hauler trial. LH trial will be finished before the 140 anyway and there is no guarantee the 140 is going g to get across the finish line.preserve cash and fight another day
Second , with just Longhaulers should no EUA come in, focus on getting HIV approval within 12 months and continue to focus on triple negative breast cancer
Third , on the financial front , If BP isn’t willing to partner on Covid then look at a flatout buyout by BP. With the results of Cd12 falling short and if no EUA comes in during those 30 days, if Cytodyn has to borrow money it’s going to come at a higher price on what they need to give up and the interest rate they pay. In other words , we are getting into an area where dilution may kick in in a bigger way and terms will be ugly
And last , Dr Kelly needs to work with the board to decide if we proceed with NP as CEO. This would be a difficult decision for the Doctor but when things get very difficult , the Chairman needs to act decisively if they feel a replacement will run the company better and the move would work better for shareholders.